Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perifosine + Capecitabine in Metastatic Colorectal Cancer
NCT00398879Phase 2Completed
- Sponsor
- COSCIENS Biopharma Inc.
- Start
- Aug 2005
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of perifosine in colorectal cancer (CRC), sponsored by COSCIENS Biopharma Inc.. Started Aug 2005; status: completed.
02
Drugs
perifosine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00398879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00398879.